“I wasn't surprised by the result.” Call it the Joao Factor. Fonseca only fed that frenzy in his press conference. “When I arrived here, my first goal was to qualify for the main draw,” he ...

Data from expansion arms in Phase 1/1b clinical trial evaluating WTX-124 as monotherapy expected in first half of 2025 to guide regulatory engagement on potential registrational pathways ...

FormFactor’s FORM shares have lost 26.1% in the trailing six months, underperforming the broader Zacks Computer and Technology sector’s return of 3.7% and the Zacks Electronics- Semiconductors ...

Online form builders deal with tons of personal user data and employ multi-layered security to prevent leaks. Platforms like Cognito Forms come with 2FA (two-factor authentication) to prevent ...

A weekly newsletter by David Pierce designed to tell you everything you need to download, watch, read, listen to, and explore that fits in The Verge’s universe.

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the semiconductor manufacturing industry, including FormFactor (NASDAQ:FORM) and its peers.

Find the best mini PC for your next project with my round-up of top small-form desktop computers. As hardware editor, my team and I have built, benchmarked, and reviewed a broad range of mini ...

WTX-330 is under clinical development by Werewolf Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I drugs for Colorectal Cancer have a 75% phase transition ...

A factor is an intermediary agent that provides ... Although factoring is a relatively expensive form of financing, it can help a company improve its cash flow. Factors provide a valuable service ...